FDA Approved: ABIRATERONE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma Pharmaceuticals USA Inc.'s original application for a generic abiraterone acetate product (ABIRATERONE) for the treatment of prostate cancer.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

ORIG AP for ABIRATERONE (ABIRATERONE ACETATE)